Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus. (2026). Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(3), 302-315. https://doi.org/10.32947/ajps.v26i3.1420